FIELD: medicine.
SUBSTANCE: marker is presented by determining the patient's serum neopterin level. The neopterin level is determined by enzyme-linked assay (ELISA). If the neopterin level exceeds 10.0 nmole/l, a probability of the postcholecystectomy syndrome development is considered to be high.
EFFECT: method provides higher effectiveness and reliability of predicting the postcholecystectomy syndrome development in the patients suffered cystectomy.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING INTESTINAL BACTERIAL OVERGROWTH FOLLOWING CHOLECYSTECTOMY IN PATIENTS | 2012 |
|
RU2497122C1 |
| METHOD FOR PREDICTIOM OF STRUCTURE OF COMMON BILE DUCT AND HEPATICOPANCREATIC AMPULLA STENOSIS IN PATIENTS AFTER CHOLECYSTECTOMY DUE TO CHOLELITHIASIS | 2016 |
|
RU2635962C1 |
| METHOD FOR THE PREVENTION OF POSTCHOLECYSTECTOMY SYNDROME | 2021 |
|
RU2760538C1 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTION-TYPE ODDI'S SPHINCTER DYSSYNERGIA FOLLOWING CHOLECYSTECTOMY | 2009 |
|
RU2416802C1 |
| METHOD FOR DIAGNOSTICS OF TYPE III ODDI'S SPHINCTER DYSFUNCTION IN PATIENTS OPERATED DUE TO CHOLELITHIASIS | 2016 |
|
RU2629396C1 |
| METHOD FOR PREDICTION OF DEVELOPING FUNCTION-TYPE ODDI'S SPHINCTER DYSSYNERGIA FOLLOWING CHOLECYSTECTOMY | 2009 |
|
RU2414712C1 |
| METHOD FOR ESTIMATION OF FATTY TISSUE INFLAMMATION ACTIVITY IN CASE OF ABDOMINAL OBESITY | 2014 |
|
RU2561039C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| METHOD FOR REHABILITATION TREATMENT AT RESORT OF PATIENTS WITH POSTCHOLECYSTECTOMY SYNDROME | 2015 |
|
RU2583589C1 |
| METHOD FOR PREDICTION OF DEVELOPING CHOLELITHIASIS | 2011 |
|
RU2461827C1 |
